Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Adverse drug events (ADEs) and opportunistic infections (OIs) associated expenditures among rural Chinese patients, stratified by CD4 cell count (N = 276)

From: Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs

Disease CD4 cell count (cells/μL) Prevalence (%) Expenditures (US dollars)
    Medications Tests for diagnosis Other medical services Total
ADEs <100 64.9 (37/57) $92 $14 $37 $142
  100-199 71.9 (73/103) $79 $11 $48 $138
  ≥200 61.2 (71/116) $42 $6 $16 $64
  P value 0.32 a 0.04 b 0.04 b 0.01 b 0.04 b
OIs <100 66.7 (38/57) $138 $37 $99 $274
  100-199 57.3 (59/103) $30 $6 $14 $51
  ≥200 19.0 (22/116) $12 $1 $5 $19
  P value <0.001 a <0.01 b <0.01 b <0.01 b <0.01 b
  1. aCochran-Mantel-Haenszel χ2 test.
  2. bKruskal-Wallis test.